Key result
Amphotericin plus 5-flucytosine followed by isavuconazole clears refractory prosthetic Candida albicans fungemia.
Why the study?
Endocarditis from candidemia is a rare but potentially fatal complication, and managing infection with irrecoverable prosthetic devices poses unique clinical and pharmacological challenges.
Case Report (n=1)
Isavuconazole may serve as a viable option for chronic lifelong suppression of Candida endocarditis in patients with irrecoverable prosthetics and prolonged QTc interval.
Answers are grounded in this paper and cite their sources.
Describes candidemia endocarditis in comorbid patient; leaves open optimal antifungal duration and source control in complex cases.
BACKGROUND: Candidemia is the fourth most common nosocomial bloodstream infection. Endocarditis from candidemia is a rare but possibly fatal complication. The efficacy of amphotericin and echinocandins for induction and azoles for suppression has been well studied. Source control of infection, including removal of foreign bodies, remains the cornerstone for the success of any antifungal therapy. CASE PRESENTATION: We are describing a case of a 63-years old patient with multiple comorbidities who developed candidemia secondary to Candida albicans. The prospect of curing the fungemia was made difficult by prosthetic devices, including prosthetic heart valves, intracardiac defibrillator, and inferior vena filter, which could not be extracted due to poor cardiovascular status and higher postoperative mortality risk. Combination therapy with amphotericin and 5-Flucytosine (5FC) was used with the first recurrence. Suppression with fluconazole was contraindicated due to prolonged corrected QT (QTc) interval. Isavuconazole was employed for chronic lifelong suppression. CONCLUSION: Retaining prosthetics in higher surgical risk patients presents us with unique clinical and pharmacological challenges regarding breakthrough infections, drug interaction, and side effects from prolonged suppressive therapies.
No takes yet. Share an insight, caveat, or question.
Sahra et al. (2023) conducted a case report in Candida albicans Endocarditis (n=1). Amphotericin B, 5-Flucytosine, and Isavuconazole was evaluated on Clinical improvement and culture clearance. Combination therapy with amphotericin and 5-flucytosine followed by chronic suppression with isavuconazole successfully cleared breakthrough Candida albicans fungemia in a patient with irrecoverable prosthetics.
Synapse has enriched 10 related papers. Consider them for comparative context: